Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant
- 9 August 2020
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (11) , e28528
Abstract
No abstract availableKeywords
All Related Versions
This publication has 10 references indexed in Scilit:
- Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow TransplantationTransplantation and Cellular Therapy, 2017
- Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: A national cohort studyInternational Journal of Cancer, 2016
- Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Uncommon non‐Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approachesBritish Journal of Haematology, 2015
- Non‐anaplastic peripheral T‐cell lymphoma in children and adolescents – a retrospective analysis of the NHL‐BFM study groupBritish Journal of Haematology, 2014
- Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfallsLaboratory Investigation, 2013
- A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2011
- Hepatosplenic T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patientsBlood, 2003
- Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990Leukemia, 2000
- Occurrence of cancer in women with Turner syndromeBritish Journal of Cancer, 1996